The return of the dread
Sulaiman, a headload worker at Valanchery, had never missed the Workers' Day celebrations in over 20 years. But this May Day was different.
Instead of joining his co-workers, Sulaiman rushed his 42-year-old wife to clinics and hospitals, her health faltering with each passing moment. By midnight, she lay critically ill in the emergency wing of the EMS Memorial Cooperative Hospital at Perinthalmanna.
In the early hours of May 2, in the intensive care unit (ICU)'s sterile silence, she slipped into a coma. Her loved ones' world began shrinking to a terrifying reality as Sulaiman and their three children waited in frozen worry.
Their house at Thaniyappankunnu in Valanchery municipality stood still and silent, its doors locked since that fateful day. In the portico, two plastic chairs sat dusty and abandoned. Washed clothes flapped gently on a clothesline beneath a tarpaulin while Sulaiman's Hero bike lay idle behind the house. The 15-cent compound remained untouched. The locked house and its eerie compound provided a poignant reminder of life paused.
Nine wards within a three-kilometre radius of their house, encompassing areas of Valanchery municipality and the neighbouring panchayats of Marakkara, Edayur, and Athavanad, were declared containment zones on May 8, the day the woman tested positive for the deadly Nipah virus.
The State Health department sprang into action with Minister for Health Veena George herself rushing to Malappuram to formally announce the confirmation of the Nipah case.
Three cases in 10 months
Within 10 months since July last year, Malappuram reported three Nipah cases. A 14-year-old schoolboy succumbed to Nipah at Chembrassery, near Pandikkad, in July last year, followed by the death of a 24-year-old man from Naduvath, near Wandoor, in September. The Valanchery woman, the latest Nipah patient, fights for her life in the ICU with encephalitis having plunged her into a coma.
'We are all praying for her to come back,' say her neighbours K. Balakrishna and his wife Savithri. They appeared unfazed by Nipah. So was T. Bindu, another neighbour. 'It can affect anyone; it just happened to be her,' Balakrishna and Savithri add with a shrug.
They had not interacted with the woman since she fell ill with fever and headache on April 25. 'We may be close, but we don't visit like we used to. We would chat from across the tree-lined boundary of our homes,' Savithri explains.
Deepening mystery
The mystery surrounding the woman's Nipah infection deepens as her neighbours report that she rarely ventured out and mostly stayed indoors. 'Whenever she went out, she would be with her husband on his bike,' recounts Balakrishna. The source of her infection remains unknown.
'We know that days before falling ill, she had visited her siblings at Thiruvegapura in Palakkad district, where she exchanged fruits with them,' says Parassery Veerankutty, the municipal councillor representing Thaniyappankunnu ward.
He has been at the forefront to help the health and animal husbandry officials who conducted surveys in the area, and to spread awareness about the health protocols to be followed, including the isolation, and precautions against the spread of the virus.
'Masks are a must when we are among people. Better be safe than sorry,' Veerankutty cautions a small group of youngsters at Thaniyappankunnu, reminding them of the importance of following the guidelines issued by the health workers and taking the required precautions.
The Nipah-affected woman's house compound and surroundings were quintessential Malappuram with lush trees of different sizes thriving in the area. There were mango, jackfruit, papaya, guava, and bilimbi fruit trees aplenty. A small bilimbi tree laden with fruits stood sentinel at the front right corner of her house. Behind, an unused one-acre plot belonging to another joint family offered a veritable feast, overflowing with mangoes and jackfruits that likely drew fruit bats to the area.
'We strongly suspect a bat-bitten fruit as the source of her infection; but without evidence, it is hard to say for sure,' says C. Shubin, District Surveillance Officer, Malappuram.
Dr. Shubin, supported by District Medical Officer R. Renuka and her team, has been instrumental in detecting the three Nipah cases in Malappuram over the past 10 months. 'We ought to be prepared for further cases,' warns Dr. Renuka.
Dr. Renuka and the team had issued a pre-emptive warning against potential outbreaks of deadly diseases like Nipah before the summer peaked. They had advised the people against consuming fallen fruits, especially those bitten by birds and bats. People were also warned to maintain strict hygiene while dealing with domestic animals.
Surveillance of certain ailments, particularly encephalitic cases, has been ramped up in Malappuram since 2022. Apart from government hospitals, major tertiary hospitals in the district too have been trained to deal with encephalitic cases, especially with the Nipah risk in mind.
Nipah infection often progresses to Acute Encephalitis Syndrome (AES) after initial symptoms like fever, headache, and vomiting. Monitoring AES cases helps detect early warning signs of an outbreak, enabling timely treatment and interventions, according to medical experts.
'We identified all the three Nipah cases reported in Malappuram since last year through this surveillance. No AES or Acute Respiratory Distress Syndrome (ARDS) cases can go unreported under the current surveillance system, whether in private or government hospitals,' says Dr. Shubin. 'Our private hospitals are cooperative in promptly reporting the cases,' he adds.
Malappuram's major tertiary private hospitals are equipped with ICU isolation facilities, enabling them to effectively manage viral outbreaks like Nipah. 'Handling a Nipah suspect is no longer a cause for concern,' asserts Shubin.
Enhanced surveillance
Experts caution that eliminating Nipah may be impossible due to the complexity of factors leading to outbreaks. However, enhanced surveillance of AES cases can facilitate early detection and swift isolation of contacts, potentially preventing transmission, they say.
Research has identified fruit bats, specifically Pteropus species or flying foxes, as the natural reservoirs of Nipah virus. While the exact transmission route to humans remains unclear, it is suspected that contaminated fruits, bitten or licked by bats, may play a role in spreading the virus. The possibility of an intermediary host facilitating transmission is still being investigated.
Bat researcher Sreehari Raman, assistant professor at Kerala Agricultural University, who identified six fruit-eating bats among the 48 bat varieties found in Kerala, says that ectoparasites living on the body of bats may work like vectors. 'It is also a possibility apart from the transmission through fruits bitten by bats,' says Sreehari.
Another potential transmission route is through the consumption of bats, a practice still observed among some indigenous tribes in Kerala. 'I encountered several individuals who ate bats during my research, but the practice appears to have decreased following the Nipah outbreak and awareness campaigns,' he says.
Some unusual observations
His encounters with bats have led to unusual observations such as bats eating fruits stored in shops. 'I captured footage of bats feeding on bananas in a fruit shop. After showing the video to the shop owner, he promptly covered the potential entry points with a large net to prevent further access for the flying foxes,' he says.
Human activities such as urbanisation and deforestation are suspected to be a leading cause of virus spillover. According to studies, driving away bats by destroying roosting trees can cause changes in their habits. 'The viral load seems to be the highest during the breeding season. But this has to be studied to say for certain,' says Sreehari.
According to health officials, preventing bat virus spread requires a two-pronged approach: swift outbreak response and vigilant bat population monitoring. The World Health Organisation (WHO) has endorsed the One Health approach to integrate human, animal and environmental health as part of controlling zoonotic diseases like Nipah. 'It promotes a balanced relationship between humans, animals, and nature,' says Health Minister Veena George.
Deaths of cats, fowls
In Valanchery, animal husbandry officials joined the anti-Nipah drive by surveying within a 500-metre radius of the Nipah patient's house. They collected animal samples for antibody detection. The recent deaths of cats and fowls in the area are still a cause for concern amid intensified fever surveillance by health officials.
'We are doing a combined field investigation as part of the One Health concept. If the virus is traced early in animals, the spread can be contained easily,' says T.N. Anoop, district programme manager of the National Health Mission.
Research by the Indian Council for Medical Research's National Institute of Virology, Pune, found Nipah antibodies in bats across 10 States, including Kerala, Tamil Nadu and Maharashtra. However, Kerala, particularly Malabar, frequently reports Nipah outbreaks, sparking curiosity about the underlying reasons for this regional concentration.
According to A.S. Anoop Kumar, the critical care specialist who identified the deadly virus when Nipah broke out for the first time in Kerala in 2018, Nipah cases might be going undetected in other States due to limited testing. Kerala's frequent Nipah cases could be due to the State's enhanced vigil and routine screening, he feels.
Extent of virulence
The high mortality rate (70% and above) of Nipah virus makes it a matter of significant concern. Investigating whether the current strain retains the same virulence as the 2018 outbreak is crucial for understanding the outbreak's potential severity and guiding public health responses. 'I think it is less virulent now. That's why the rate of secondary infection went down in the latest incidence,' says Mohammed Ismail, former deputy district medical officer.
But Dr. Anoop disagrees. 'We have a solid surveillance system and a clear action plan. Unless studies prove it, we can't say the virus has lost its virulence,' he says.
As Sulaiman and his children are taking turns outside the ICU of the hospital all through the day hoping for her early return to normal life, medical experts are working overtime to help her battle the crisis. The villagers are also keeping her in their prayers to see her come back to a healthy life.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Mint
10 hours ago
- Mint
India's drug regulator plans overhaul of Schedule H for prescription medicines
New Delhi: Drugs Controller General of India (DCGI), the country's top drug regulator, is planning a complete overhaul of medicines listed under Schedule H of the Drugs and Cosmetics Rules, 1945, which governs the sale of prescription drugs, said an official aware of the matter and documents reviewed by Mint. Also Read | Key drugs, diagnostics run short in public health centres, govt raises alarm The proposed revamp is driven by concerns, including a rise in antimicrobial resistance (AMR) from self-medication and rampant use of antibiotics purchased over the counter without prescription, the official said. Schedule H includes drugs that cannot be purchased or sold on retail without a doctor's prescription. This overhaul will involve updating the list of prescription drugs by incorporating new medicines and formulations that have been introduced in the market in the recent past. 'The issue related to making suitable reforms in the drug regulatory system has been in discussion for quite some time now. The exercise is part of India's fight against irrational use of antimicrobial medicines, which are used to prevent and treat infectious diseases in humans, animals and plants, including antibiotics, antivirals, antifungals and antiparasitics," said the official on the condition of anonymity. Also Read | What America has got wrong about gender medicine In 2022, a high-level expert committee was constituted by the health ministry to review and revise Schedule H Drugs to recommend comprehensive changes in the drug regulatory regime to reflect global best practices as well as domestic requirements. Remdesivir, dexamethasone, favipiravir, ivermectin and mebrofenin are some of the drugs that are proposed to be added to Schedule H. Right now, there are around 536 drugs under Schedule H. The committee had discussed the existing regulatory framework in detail and noted that the drugs that are not included in Schedule G, H, H1 and X can be easily sold in the country without prescription of a Registered Medical Practitioner (RMP) and it is 'not in public interest", according to the documents reviewed by Mint. Also Read | ICMR gets a breakthrough in attempts to develop first indigenous Nipah virus medicine 'There are many drugs used for various indications like diabetes, TB, heart disease, pain killers etc which are put in special categories like anti-diabetic, anti-pain relief, anti-depressants, anticoagulant drugs, and cardiovascular drugs of the Drug Rule. However, these drugs should fall in schedule H. So, efforts are being made to streamline this," said the official. The expert panel recommended a revamp of the Schedule H. 'Schedule H includes drugs of various categories which require prescription of RMP for their retail sale. The Schedule H needs to be updated regularly to incorporate the new drugs introduced in the market from time to time as well as to review the prescription status of different drugs in the present context. Such regular updates are crucial in the current context to address various regulatory challenges leading to irrational use of drugs, including antibiotics and development of anti-microbial resistance," the documents showed. Wrong or over-use of these medicines can lead to the emergence of antimicrobial resistance (AMR), which is hard to treat and can cause further infections. The committee has proposed more than 700 drugs to be added to the Schedule H drugs list in addition to the existing drugs, as per the documents. The committee also reviewed various aspects of the drugs like their indication, route of administration, international prescription status, abuse or misuse potential, human/ veterinary use, therapeutic/ prophylactic usage etc. When the committee reviewed Schedule G, it opined that drugs mentioned under this list bear caution that 'it is dangerous to take this medicine except under medical supervision". While Schedule G drugs carry a strong caution about medical supervision, the rules governing their sale did not, in the past, explicitly mandate an RMP prescription for every single sale, unlike Schedule H drugs. The committee has recommended the addition of several categories of drugs, namely cardiovascular drugs, neurological drugs, respiratory drugs, anesthetic drugs, antiemetic drugs, immunological drugs, genito-urinary drugs, non-steroidal anti-inflammatory drug, and all sterile formulations of any drug to schedule H.


Time of India
a day ago
- Time of India
Viral truths
Covid's return not a big worry. But a case in Delhi HC shows what's worrying when it comes to outbreaks It is safe to assume that had Delhi HC not issued a notice to Centre for failing to present in court minimum standards for sample collection, most wouldn't have known that India has no SOP mandated for diagnostic labs. Protocols of course exist, but SOPs are not mandatory. This case has gained traction given the rise in Covid cases. Delhi HC sounded a note of caution. This is despite the fact that GOI, epidemiologists and medical fraternity all agree that given the endemicity of Covid and that almost 70% of the population is fully vaccinated, this round of Covid is little more than 'seasonal flu'. There is no cause for worry. But that is not to say now is not the time for the whole preparedness-shebang to kick in – from wearing masks to surveilling the spread with more testing. Cases are climbing, as are deaths. All deaths have been of those with Covid, not of Covid. Point is, India's burden of comorbidity is massive – diabetes to TB to COPD, chronic kidney disease, and cancer patients & survivors. Against this reality, it's hard to see why Union health ministry wasn't more proactive to Delhi HC's 2023 order to formulate minimum standards for sample collection. It is not about Covid alone. Our healthcare systems must brace for viral outbreaks at any point given the two major challenges today – a dizzying number of dangerous viruses (H5N1, dengue, chikungunya, Nipah, Zika are household terms) and antibiotic-resistant bacteria. Preparedness and quick response make healthcare systems more resilient. Govt estimates put Covid deaths at 5.3L. Lessons were learned. Every weak link in public health machinery was exposed. In the three years since, how many of these weaknesses have been fixed? Is surveillance better? Is the expanded virus research & diagnostic laboratory network fully equipped? Variant identification took a long time during the pandemic. Have we fixed that? Surveillance systems, healthcare infra and community engagement ensure public health. Covid may not be a threat, but as epidemiologist Gagandeep Kang put it: 'What we know we don't know is when, where and what our next disease outbreak will be.' An SOP for sample collection and transport seems to be the very least govt can do. Facebook Twitter Linkedin Email This piece appeared as an editorial opinion in the print edition of The Times of India.


Time of India
a day ago
- Time of India
AIIMS Nagpur is Maharashtra's first medical college to get BSL-3 lab
Nagpur: In a significant step forward for public health in Vidarbha and surrounding areas, AIIMS Nagpur will soon be home to Maharashtra's first Bio-Safety Level-3 (BSL-3) laboratory in a medical college, thanks to a tie-up with the National Centre for Disease Control (NCDC), New Delhi. This cutting-edge lab will help doctors quickly detect and respond to deadly infections like Nipah, Zika, bird flu, and even viruses used in bioterrorism. For common people, this means faster diagnosis, better protection during disease outbreaks, and stronger health systems in our region. "This BSL-3 lab will make AIIMS Nagpur a hub for detecting dangerous infections early, which is crucial to stop them from spreading," said Dr Prashant P Joshi, executive director of AIIMS Nagpur. Currently, the only BSL-3 lab in Maharashtra is at the National Institute of Virology, Pune. Once operational, the Nagpur lab will not only serve patients but will also train microbiologists and technicians from across the state to fight infectious diseases better. Dr Meena Mishra, who heads the department of microbiology and is the project in charge, explained, "BSL-3 labs are highly secure and are built to handle very dangerous germs. These germs can cause severe disease and can spread from animals to humans, like Japanese Encephalitis, Mpox, or Nipah virus. With this lab, we'll be able to test and research them safely right here in Nagpur." Unlike the existing BSL-2 lab at AIIMS, which handles common infections like dengue and Covid-19, the BSL-3 lab will work with much riskier pathogens. It will have features like airtight rooms, HEPA filters to clean the air, and specially trained staff in full protective gear. The lab is being set up under the PM-Ayushman Bharat Health Infrastructure Mission. The NCDC has allotted Rs30 crore for it — Rs25 crore for infrastructure and Rs5 crore for equipment and testing kits. Experts from Delhi, including Sunil Bharadwaj (additional director, NCDC), Dr Ankur Garg (joint director), and Dr Aradhana Bhargava (nodal officer for the lab), recently signed the MoU with AIIMS authorities during their visit to Nagpur. Once ready, this BSL-3 lab will become a crucial defence system against any future epidemic or bio-emergency, ensuring that people in Central India don't have to wait or travel far for testing and treatment. "This initiative strengthens India's ability to deal with public health emergencies. We're proud to bring such a facility to Nagpur," Dr Joshi added.